Dr. Soto presented his research findings at the CVRI Research Day on June 6, 2025 at Bernard Snell Hall – Walter C. Mackenzie Health Sciences Ctr (U of A)
Valencia LM, Martinez Montano Y, Gomez JA, Brito V, Hernandez A, Sarduy R, Fernandez Calienes AF, Proctor SD, Soto Y. Expression characterization, and antiatherogenic effects of the anti-sulfated glycosaminoglycans mAb chP3R99 from CHO-K1 and HEK293 cells.
